Depression Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

Depression Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

The global depression drugs market is expected to grow at a CAGR of 2.5% during 2019-2024. Depression drugs, or antidepressants, are a range of medications that are consumed for the treatment of mental disorders such as social anxiety and depression. They are intended to balance the functioning of neurotransmitters such as serotonin in the brain, thus controlling the mood and emotions of the patient. Depression and related mental disorders are characterized by the absence of positive emotions, constant low mood and numerous cognitive, physical, behavioral and emotional symptoms. These drugs can assist in relieving the symptoms of anxiety, seasonal affective disorder and dysthymia. Antidepressant medications include the use of Selective Serotonin Reuptake Inhibitors (SSRIs), atypical antidepressants and Monoamine Oxidase Inhibitors (MAOIs) that are most effective when consumed along with regular therapeutic sessions.

The growing prevalence of major depressive disorders across the globe is the key factor driving the growth of the market. Depression in adolescents and adults is increasing due to several factors including social isolation, improper dietary habits and work-life imbalance. Furthermore, the increasing geriatric population across the globe that suffers from isolation from family and friends, along with other health-related issues, are also augmenting the growth of the market. However, there is rising awareness about depression as a psychological issue and methodologies to cure it, which has enhanced the adoption of these drugs among patients of all age groups. Additionally, the emergence of novel techniques for the development of antidepressants with minimal side-effects and prolonged results, along with the acceptance of new medications, is also favoring the market growth. For instance, psychedelics such as ketamine are widely considered to ease the symptoms of depression and provide relief.

IMARC Group’s latest report provides a deep insight into the global depression drugs market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the depression drugs market in any manner.

Report Coverage:

Historical, Current and Future Market Trends

Market Breakup by Drug Class:
Atypical Antipsychotics
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Selective Serotonin Reuptake Inhibitors (SSRIs)
Central Nervous System (CNS) Stimulants
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Others

Market Breakup by Disorder Type:
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others

Market Breakup by Drug Type:
Generic Drugs
Branded Drugs

Market Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Market Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:
The report has also analyzed the competitive landscape of the market with some of the key players being Otsuka Pharmaceutical, Pfizer, Eli Lilly and Company, AstraZeneca, Novartis, Bristol-Myers Squibb, GlaxoSmithKline, Takeda Pharmaceutical Company, Allergan, Johnson & Johnson, Zhejiang NHU Company Ltd, Sebela Pharmaceuticals, etc.

Key Questions Answered in This Report:

How has the global depression drugs market performed so far and how will it perform in the coming years?
What are the key regional markets in the global depression drugs industry?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the disorder type?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the global depression drugs industry?
What are the key driving factors and challenges in the global depression drugs industry?
What is the structure of the global depression drugs industry and who are the key players?
What is the degree of competition in the global depression drugs industry?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Depression Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Drug Class
5.4 Market Breakup by Disorder Type
5.5 Market Breakup by Drug Type
5.6 Market Breakup by Distribution Channel
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Drug Class
6.1 Atypical Antipsychotics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Selective Serotonin Reuptake Inhibitors (SSRIs)
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Central Nervous System (CNS) Stimulants
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Tricyclic Antidepressants
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Monoamine Oxidase Inhibitors
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Disorder Type
7.1 Major Depressive Disorder
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Obsessive-Compulsive Disorder
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Generalized Anxiety Disorder
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Panic Disorder
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Drug Type
8.1 Generic Drugs
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Branded Drugs
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Europe
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Asia Pacific
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porter’s Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Otsuka Pharmaceutical
15.3.2 Pfizer
15.3.3 Eli Lilly and Company
15.3.4 AstraZeneca
15.3.5 Novartis
15.3.6 Bristol-Myers Squibb
15.3.7 GlaxoSmithKline
15.3.8 Takeda Pharmaceutical Company
15.3.9 Allergan
15.3.10 Johnson & Johnson
15.3.11 Zhejiang NHU Company Ltd
15.3.12 Sebela Pharmaceuticals
List of Figures
Figure 1: Global: Depression Drugs Market: Major Drivers and Challenges
Figure 2: Global: Depression Drugs Market: Sales Value (in Billion US$), 2013-2018
Figure 3: Global: Depression Drugs Market: Breakup by Drug Class (in %), 2018
Figure 4: Global: Depression Drugs Market: Breakup by Disorder Type (in %), 2018
Figure 5: Global: Depression Drugs Market: Breakup by Drug Type (in %), 2018
Figure 6: Global: Depression Drugs Market: Breakup by Distribution Channel (in %), 2018
Figure 7: Global: Depression Drugs Market: Breakup by Region (in %), 2018
Figure 8: Global: Depression Drugs Market Forecast: Sales Value (in Billion US$), 2019-2024
Figure 9: Global: Depression Drugs Industry: SWOT Analysis
Figure 10: Global: Depression Drugs Industry: Value Chain Analysis
Figure 11: Global: Depression Drugs Industry: Porter’s Five Forces Analysis
Figure 12: Global: Depression Drugs (Atypical Antipsychotics) Market: Sales Value (in Million US$), 2013 & 2018
Figure 13: Global: Depression Drugs (Atypical Antipsychotics) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 14: Global: Depression Drugs (Serotonin-Norepinephrine Reuptake Inhibitors) Market: Sales Value (in Million US$), 2013 & 2018
Figure 15: Global: Depression Drugs (Serotonin-Norepinephrine Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 16: Global: Depression Drugs (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million US$), 2013 & 2018
Figure 17: Global: Depression Drugs (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 18: Global: Depression Drugs (Central Nervous System (CNS) Stimulant) Market: Sales Value (in Million US$), 2013 & 2018
Figure 19: Global: Depression Drugs (Central Nervous System (CNS) Stimulant) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 20: Global: Depression Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million US$), 2013 & 2018
Figure 21: Global: Depression Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 22: Global: Depression Drugs (Monoamine oxidase inhibitors) Market: Sales Value (in Million US$), 2013 & 2018
Figure 23: Global: Depression Drugs (Monoamine oxidase inhibitors) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 24: Global: Depression Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2013 & 2018
Figure 25: Global: Depression Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 26: Global: Depression Drugs (Major Depressive Disorder) Market: Sales Value (in Million US$), 2013 & 2018
Figure 27: Global: Depression Drugs (Major Depressive Disorder) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 28: Global: Depression Drugs (Obsessive-Compulsive Disorder) Market: Sales Value (in Million US$), 2013 & 2018
Figure 29: Global: Depression Drugs (Obsessive-Compulsive Disorder) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 30: Global: Depression Drugs (Generalized Anxiety Disorder) Market: Sales Value (in Million US$), 2013 & 2018
Figure 31: Global: Depression Drugs (Generalized Anxiety Disorder) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 32: Global: Depression Drugs (Panic Disorder) Market: Sales Value (in Million US$), 2013 & 2018
Figure 33: Global: Depression Drugs (Panic Disorder) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 34: Global: Depression Drugs (Other Disorder Types) Market: Sales Value (in Million US$), 2013 & 2018
Figure 35: Global: Depression Drugs (Other Disorder Types) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 36: Global: Depression Drugs (Generic Drugs) Market: Sales Value (in Million US$), 2013 & 2018
Figure 37: Global: Depression Drugs (Generic Drugs) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 38: Global: Depression Drugs (Branded Drugs) Market: Sales Value (in Million US$), 2013 & 2018
Figure 39: Global: Depression Drugs (Branded Drugs) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 40: Global: Depression Drugs Market: Sales through Hospital Pharmacies (in Million US$), 2013 & 2018
Figure 41: Global: Depression Drugs Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2019-2024
Figure 42: Global: Depression Drugs Market: Sales through Retail Pharmacies (in Million US$), 2013 & 2018
Figure 43: Global: Depression Drugs Market Forecast: Sales through Retail Pharmacies (in Million US$), 2019-2024
Figure 44: Global: Depression Drugs Market: Sales through Online Pharmacies (in Million US$), 2013 & 2018
Figure 45: Global: Depression Drugs Market Forecast: Sales through Online Pharmacies (in Million US$), 2019-2024
Figure 46: Global: Depression Drugs Market: Sales through Other Distribution Channels (in Million US$), 2013 & 2018
Figure 47: Global: Depression Drugs Market Forecast: Sales through Other Distribution Channels (in Million US$), 2019-2024
Figure 48: North America: Depression Drugs Market: Sales Value (in Million US$), 2013 & 2018
Figure 49: North America: Depression Drugs Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 50: Europe: Depression Drugs Market: Sales Value (in Million US$), 2013 & 2018
Figure 51: Europe: Depression Drugs Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 52: Asia Pacific: Depression Drugs Market: Sales Value (in Million US$), 2013 & 2018
Figure 53: Asia Pacific: Depression Drugs Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 54: Middle East and Africa: Depression Drugs Market: Sales Value (in Million US$), 2013 & 2018
Figure 55: Middle East and Africa: Depression Drugs Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 56: Latin America: Depression Drugs Market: Sales Value (in Million US$), 2013 & 2018
Figure 57: Latin America: Depression Drugs Market Forecast: Sales Value (in Million US$), 2019-2024
List of Tables
Table 1: Global: Depression Drugs Market: Key Industry Highlights, 2018 and 2024
Table 2: Global: Depression Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2019-2024
Table 3: Global: Depression Drugs Market Forecast: Breakup by Disorder Type (in Million US$), 2019-2024
Table 4: Global: Depression Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2019-2024
Table 5: Global: Depression Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2019-2024
Table 6: Global: Depression Drugs Market Forecast: Breakup by Region (in Million US$), 2019-2024
Table 7: Global: Depression Drugs Market Structure
Table 8: Global: Depression Drugs Market: Key Players

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook